Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a highly malignant human cancer that has increasing mortality rates worldwide. Because CD133(+) cells control tumor maintenance and progression, compounds that target CD133(+) cancer cells could be effective in combating HCC. We found that the administration of chro...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Song, Yeonhwa, Kim, Sanghwa, Lee, Hyeryon, No, Joo Hwan, Ryu, Hyung Chul, Kim, Jason, Lim, Jee Woong, Kim, Moonhee, Choi, Inhee, Seo, Haeng Ran
Format: Artigo
Langue:Inglês
Publié: MDPI 2020
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7281429/
https://ncbi.nlm.nih.gov/pubmed/32397206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12051193
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires